Guo T - Search Results

1

Development and verification of a deep learning-based m⁶A modification model for clinical prognosis prediction of renal cell carcinoma.

Chen S, Zhang E, Guo T, Wang T, Chen J, Zhang N, Wang X, Zheng J. Chen S, et al. Among authors: guo t. J Cancer Res Clin Oncol. 2023 Nov;149(15):14283-14296. doi: 10.1007/s00432-023-05169-0. Epub 2023 Aug 10. J Cancer Res Clin Oncol. 2023. PMID: 37558767

2

A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.

Chen S, Zhang E, Guo T, Shao J, Wang T, Zhang N, Wang X, Zheng J. Chen S, et al. Among authors: guo t. BMC Cancer. 2022 Jan 3;22(1):1. doi: 10.1186/s12885-021-09033-7. BMC Cancer. 2022. PMID: 34979993 Free PMC article.

3

Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm.

Chen S, Zhang E, Jiang L, Wang T, Guo T, Gao F, Zhang N, Wang X, Zheng J. Chen S, et al. Among authors: guo t. Front Immunol. 2022 Feb 7;13:798471. doi: 10.3389/fimmu.2022.798471. eCollection 2022. Front Immunol. 2022. PMID: 35197975 Free PMC article.

4

The Dual Role of USP11 in Cancer.

Guo T, Tang H, Yuan Z, Zhang E, Wang X. Guo T, et al. J Oncol. 2022 Mar 22;2022:9963905. doi: 10.1155/2022/9963905. eCollection 2022. J Oncol. 2022. PMID: 35359344 Free PMC article. Review.

5

Lactic Acid Metabolism and Transporter Related Three Genes Predict the Prognosis of Patients with Clear Cell Renal Cell Carcinoma.

Guo T, Zhang J, Wang T, Yuan Z, Tang H, Zhang D, Chen S, Wang X. Guo T, et al. Genes (Basel). 2022 Mar 30;13(4):620. doi: 10.3390/genes13040620. Genes (Basel). 2022. PMID: 35456426 Free PMC article.

6

Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma.

Chen S, Guo T, Zhang E, Wang T, Jiang G, Wu Y, Wang X, Na R, Zhang N. Chen S, et al. Among authors: guo t. Heliyon. 2022 Sep 11;8(9):e10578. doi: 10.1016/j.heliyon.2022.e10578. eCollection 2022 Sep. Heliyon. 2022. PMID: 36158103 Free PMC article.

7

HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma.

Guo T, Wang T, Zhang J, Chen S, Wang X. Guo T, et al. Transl Oncol. 2022 Dec;26:101554. doi: 10.1016/j.tranon.2022.101554. Epub 2022 Sep 30. Transl Oncol. 2022. PMID: 36191462 Free PMC article.

8

Guo T, Zhang J, Yuan Z, Tang H, Wang T, Wang X, Chen S. Guo T, et al. J Clin Med. 2022 Dec 18;11(24):7507. doi: 10.3390/jcm11247507. J Clin Med. 2022. PMID: 36556123 Free PMC article.

9

Integrative analysis of ferroptosis regulators for clinical prognosis based on deep learning and potential chemotherapy sensitivity of prostate cancer.

Guo T, Yuan Z, Wang T, Zhang J, Tang H, Zhang N, Wang X, Chen S. Guo T, et al. Precis Clin Med. 2023 Feb 2;6(1):pbad001. doi: 10.1093/pcmedi/pbad001. eCollection 2023 Mar. Precis Clin Med. 2023. PMID: 36874167 Free PMC article.

10

Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression.

Tang H, Guan Y, Yuan Z, Guo T, Tan X, Fan Y, Zhang E, Wang X. Tang H, et al. Among authors: guo t. Epigenetics. 2023 Dec;18(1):2192319. doi: 10.1080/15592294.2023.2192319. Epigenetics. 2023. PMID: 36952476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,019 results

Search Page

Filters